NASDAQ:NAOV NanoVibronix (NAOV) Stock Price, News & Analysis $0.51 0.00 (0.00%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About NanoVibronix Stock (NASDAQ:NAOV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NanoVibronix alerts:Sign Up Key Stats Today's Range$0.49▼$0.5350-Day Range$0.50▼$0.7352-Week Range$0.46▼$1.55Volume126,008 shsAverage Volume95,393 shsMarket Capitalization$1.41 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> NanoVibronix Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks5th Percentile Overall ScoreNAOV MarketRank™: NanoVibronix scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NanoVibronix.Read more about NanoVibronix's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NanoVibronix is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NanoVibronix is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNanoVibronix has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about NanoVibronix's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted18.67% of the float of NanoVibronix has been sold short.Short Interest Ratio / Days to CoverNanoVibronix has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in NanoVibronix has recently increased by 3,311.92%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNanoVibronix does not currently pay a dividend.Dividend GrowthNanoVibronix does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted18.67% of the float of NanoVibronix has been sold short.Short Interest Ratio / Days to CoverNanoVibronix has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in NanoVibronix has recently increased by 3,311.92%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment0.43 News SentimentNanoVibronix has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for NanoVibronix this week, compared to 0 articles on an average week.Search Interest4 people have searched for NAOV on MarketBeat in the last 30 days. MarketBeat Follows1 people have added NanoVibronix to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, NanoVibronix insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.60% of the stock of NanoVibronix is held by insiders.Percentage Held by InstitutionsOnly 16.39% of the stock of NanoVibronix is held by institutions.Read more about NanoVibronix's insider trading history. Receive NAOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter. Email Address NAOV Stock News HeadlinesNanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in GermanyOctober 9, 2024 | finance.yahoo.comNanoVibronix Signs Letter of Intent with Potential New DistributorSeptember 23, 2024 | finance.yahoo.comUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?October 31, 2024 | Behind the Markets (Ad)NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to StockholdersAugust 21, 2024 | finance.yahoo.comNanoVibronix Second Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.65 loss in 2Q 2023)August 18, 2024 | finance.yahoo.comNanoVibronix Announces Commencement of UroShield Clinical Study at the University of MichiganMay 22, 2024 | businesswire.comNanoVibronix Issues Letter to StockholdersMay 16, 2024 | businesswire.comNAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024May 16, 2024 | investorplace.comSee More Headlines NAOV Stock Analysis - Frequently Asked Questions How have NAOV shares performed this year? NanoVibronix's stock was trading at $1.15 at the beginning of the year. Since then, NAOV stock has decreased by 55.8% and is now trading at $0.5080. View the best growth stocks for 2024 here. How were NanoVibronix's earnings last quarter? NanoVibronix, Inc. (NASDAQ:NAOV) announced its earnings results on Wednesday, August, 14th. The company reported ($0.25) earnings per share for the quarter. The firm earned $0.82 million during the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 74.98% and a negative net margin of 83.49%. When did NanoVibronix's stock split? NanoVibronix shares split on the morning of Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were payable to shareholders after the market closes on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. How do I buy shares of NanoVibronix? Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NanoVibronix own? Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include Exela Technologies (XELA), Assertio (ASRT), Meta Platforms (META), T2 Biosystems (TTOO), NIO (NIO), Senseonics (SENS) and SNDL (SNDL). Company Calendar Last Earnings8/14/2024Today10/31/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:NAOV CUSIPN/A CIK1326706 Webwww.nanovibronix.com Phone(914) 233-3004Fax914-376-6111Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,710,000.00 Net Margins-83.49% Pretax Margin-82.75% Return on Equity-74.98% Return on Assets-43.38% Debt Debt-to-Equity RatioN/A Current Ratio2.11 Quick Ratio1.16 Sales & Book Value Annual Sales$2.28 million Price / Sales0.62 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.26Miscellaneous Outstanding Shares2,780,000Free Float2,684,000Market Cap$1.41 million OptionableNot Optionable Beta1.50 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report This page (NASDAQ:NAOV) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.